Rothbaum Wayne P.
- SEC CIK
- 0001423102
No open-market purchases or sales filed in the past year.
Current role at each company
- IOVA Iovance Biotherapeutics, Inc.Directoras of Mar 5, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Rothbaum Wayne P. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2024 (view filing) | Feb 20 | Same day | Rothbaum Wayne P.Director | PPurchase | +5.00M | $9.15 | +$45.8M | +21.7%28.1M after | |
| Sep 15, 2023 (view filing) | Sep 15 | Same day | Rothbaum Wayne P.Director | PPurchase | +5.00M | $5.30 | +$26.5M | +27.7%23.1M after | |
| Dec 2, 2022 (view filing) | Dec 2 | Same day | Rothbaum Wayne P.Director | PPurchase | +10.0M | $6.50 | +$65.0M | +124.0%18.1M after | |
| Jun 2, 2022 (view filing) | May 31-Jun 1 | 2 days | Rothbaum Wayne P.Director | PPurchase | +1.00M | $6.60 | +$6.60M | +14.1%8.07M after | 2 lots |